This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Revenue and profit rise; standalone Q2 net profit up 27%
NH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.7 pts more than Nifty Midcap 150 and 6.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone Q2 revenue rose 16% to Rs 1,185.38 crore and net profit 27% to Rs 175.63 crore. Consolidated Q2 revenue rose about 70% to Rs 2,843.99 crore and net profit was Rs 301.15 crore; H1 profit was Rs 508.42 crore. Standalone earnings margin before interest, tax, depreciation and amortisation rose, but the consolidated margin fell. Reviews were unmodified; a Rs 45.28 crore labour-code exceptional charge was in the prior-year standalone comparison.
Revenue and profit growth are positive, but the narrower consolidated margin and prior-year exceptional charge may limit stock upside.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹2,844 Cr | ₹1,644 Cr | +73.0% |
| Operating profit | ₹294.2 Cr | ₹272.8 Cr | +7.9% |
| Profit after tax | ₹301.2 Cr | ₹258.5 Cr | +16.5% |
| EBITDA margin | 19.4% | 24.5% | −5.1 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.